Sign Up Today and Learn More About Nested Therapeutics Stock
Invest in or calculate the value of your shares in Nested Therapeutics or other pre-IPO companies through EquityZen's platform.
Nested Therapeutics Stock (NETT)
Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.
About Nested Therapeutics Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Health Care
Nested Therapeutics Press Mentions
Stay in the know about the latest news on Nested Therapeutics
Heterocyclic derivative as mitogen-activated protein kinase (mek) inhibitor
patents • Apr 02, 2025
Molecular Glues Market to Register Stunning Growth During the Forecast Period (2025-2034) | DelveInsight
prnewswire • Mar 20, 2025
Heterocyclic derivative as mitogen-activated protein kinase (mek) inhibitor
patents • Feb 08, 2025
Benzofuranyl and benzothienyl compounds as p53 modulators
patents • Feb 08, 2025
Mitogen-activated protein kinase (mek) inhibitors
patents • Feb 08, 2025
Nested Therapeutics Management
Leadership team at Nested Therapeutics
Board Member
Carlo Rizzuto
Join now and verify your accreditation status to gain access to:
- Nested Therapeutics Current Valuation
- Nested Therapeutics Stock Price
- Nested Therapeutics Management
- Available deals in Nested Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nested Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Nested Therapeutics Revenue and Financials
- Nested Therapeutics Highlights
- Nested Therapeutics Business Model
- Nested Therapeutics Risk Factors
- Nested Therapeutics Research Report from SACRA Research
Trading Nested Therapeutics Stock
How to invest in Nested Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Nested Therapeutics through EquityZen funds. These investments are made available by existing Nested Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Nested Therapeutics stock?
Shareholders can sell their Nested Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
